EHA Library - The official digital education library of European Hematology Association (EHA)

SCREENING OF NUDT15 GENE VARIANTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Author(s): ,
Deniz Aslar Oner
Affiliations:
Lösante Hospital,ANKARA,Turkey
,
Dilara Fatma Akin
Affiliations:
Lösante Hospital,ANKARA,Turkey
,
Kadir Sipahi
Affiliations:
Lösante Hospital,ANKARA,Turkey
,
Mine Mumcuoglu
Affiliations:
Lösante Hospital,ANKARA,Turkey
,
Nergiz Oner Battaloglu
Affiliations:
Lösante Hospital,ANKARA,Turkey
,
Serpil Tasdelen
Affiliations:
Lösante Hospital,ANKARA,Turkey
,
Ustun Ezer
Affiliations:
Lösante Hospital,ANKARA,Turkey
,
Suna Emir
Affiliations:
Lösante Hospital,ANKARA,Turkey
Emin Kürekci
Affiliations:
Lösante Hospital,ANKARA,Turkey
(Abstract release date: 05/18/17) EHA Library. Alar Öner D. 05/18/17; 182333; PB1619
Deniz Alar Öner
Deniz Alar Öner
Contributions
Abstract

Abstract: PB1619

Type: Publication Only

Background
In cells, while DNA bases can be protected by double helix formation and nucleosome packaging, deoxyribonucleotide triphosphates are unprotected, thus, are vulnarable to damage. One of the enzymes which are responsible for removing damaged nucleotides is Nudix hydrolase15 (NUDT15). NUDT15 works as a negative regulator in thiopurine metabolism. Thioguanines are active metabolites of thiopurines. Mechanisms of action of thioguanines are disruption of DNA synthesis and induction of apoptosis. NUDT15 inhibits incorrect base pairing and apoptosis through catalysis of thioguanine hydrolysis. Tanaka et al. claimed that, besides TPMT variants in Japanese patients, there might be possible additional factors that may influence thiopurine toxicity. They reported that NUDT15 variants are more specific to Asian population when compared to European people. As far as we know, this is the first study on screening of possible variants in the first exon of NUDT15 in Turkish children with precursor B-cell acute lymphoblastic leukemia (Pre-B ALL).

Aims

In this study, our aim was screening of gene variants in first exon of NUDT15 in pediatric group of patients diagnosed with Pre-B ALL.

Methods

Our study group was composed of 83 patients aged between 1-15 diagnosed with Pre B-ALL at Lösante Hospital. DNA samples were isolated by using MagNa Pure isolation system. First exon of NUDT15 was amplified by PCR reaction. After PCR purification, sequencing was performed.

Results
After screening of first exon of NUDT15, we detected two variations. First variation was intronic insertion which was defined as rs3831098 (c.158+52_158+53insGGGGCGTGCGCAGAGGGACGATCTC). The other intronic variation was defined as rs79687000 (c.158+117C>T). rs3831098 was determined in one of the 83 patients and rs79687000 was found in three out of the 83 patients.

Conclusion

The changes in NUDT15 that we found have not been previously reported in pediatric ALL patients. We do not know if these changes have an effect on pre-mRNA or “splice” regions and ALL. This issue needs further investigations in a large number of children with leukemia. We are planning the screening of other exons of NUDT15 in order to evaluate for possible applications to clinical practice (e.g. cytopenia).

Session topic: 1. Acute lymphoblastic leukemia - Biology

Keyword(s): mutation analysis, Leukemia, Children

Abstract: PB1619

Type: Publication Only

Background
In cells, while DNA bases can be protected by double helix formation and nucleosome packaging, deoxyribonucleotide triphosphates are unprotected, thus, are vulnarable to damage. One of the enzymes which are responsible for removing damaged nucleotides is Nudix hydrolase15 (NUDT15). NUDT15 works as a negative regulator in thiopurine metabolism. Thioguanines are active metabolites of thiopurines. Mechanisms of action of thioguanines are disruption of DNA synthesis and induction of apoptosis. NUDT15 inhibits incorrect base pairing and apoptosis through catalysis of thioguanine hydrolysis. Tanaka et al. claimed that, besides TPMT variants in Japanese patients, there might be possible additional factors that may influence thiopurine toxicity. They reported that NUDT15 variants are more specific to Asian population when compared to European people. As far as we know, this is the first study on screening of possible variants in the first exon of NUDT15 in Turkish children with precursor B-cell acute lymphoblastic leukemia (Pre-B ALL).

Aims

In this study, our aim was screening of gene variants in first exon of NUDT15 in pediatric group of patients diagnosed with Pre-B ALL.

Methods

Our study group was composed of 83 patients aged between 1-15 diagnosed with Pre B-ALL at Lösante Hospital. DNA samples were isolated by using MagNa Pure isolation system. First exon of NUDT15 was amplified by PCR reaction. After PCR purification, sequencing was performed.

Results
After screening of first exon of NUDT15, we detected two variations. First variation was intronic insertion which was defined as rs3831098 (c.158+52_158+53insGGGGCGTGCGCAGAGGGACGATCTC). The other intronic variation was defined as rs79687000 (c.158+117C>T). rs3831098 was determined in one of the 83 patients and rs79687000 was found in three out of the 83 patients.

Conclusion

The changes in NUDT15 that we found have not been previously reported in pediatric ALL patients. We do not know if these changes have an effect on pre-mRNA or “splice” regions and ALL. This issue needs further investigations in a large number of children with leukemia. We are planning the screening of other exons of NUDT15 in order to evaluate for possible applications to clinical practice (e.g. cytopenia).

Session topic: 1. Acute lymphoblastic leukemia - Biology

Keyword(s): mutation analysis, Leukemia, Children

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies